Struggling biotech’s revenue and profit plunged. Wall Street saw something to cheer. – [Sepe.gr]

Novavax’s stock surged 30 percent Tuesday, it’s biggest one-day gain in more than two years as the struggling vaccine maker pledged to slash costs and disclosed promising results of vaccines in development. Δείτε περισσότερα: The Washington Post